These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 17125712

  • 1. [Coronary disease risk and prevalence of heart disease in primary care patients with hypertension and renal disease].
    Cosín-Aguilar J, Hernándiz-Martínez A, Arístegui-Urrestarazu R, Masramón-Morell X, Aguilar-Llopis A, Rodríguez-Padial L, Zamorano-Gómez JL, Researchers for the CORONARIA study.
    Rev Esp Cardiol; 2006 Oct; 59(10):1026-32. PubMed ID: 17125712
    [Abstract] [Full Text] [Related]

  • 2. [Overweight and obesity in hypertensive Spanish patients. The CORONARIA study].
    Cosín Aguilar J, Hernándiz Martínez A, Masramón Morell X, Arístegui Urrestarazu R, Aguilar Llopis A, Zamorano Gómez JL, Armada Peláez B, Rodríguez Padial L.
    Med Clin (Barc); 2007 Nov 10; 129(17):641-5. PubMed ID: 18005629
    [Abstract] [Full Text] [Related]

  • 3. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.
    Assmann G, Schulte H.
    Am Heart J; 1988 Dec 10; 116(6 Pt 2):1713-24. PubMed ID: 3202078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amlodipine reduces predicted risk of coronary heart disease in high-risk patients with hypertension in Spain (The CORONARIA Study).
    Zamorano J, Rodriguez Padial L, Cosín J, Hernandiz A, Gutierrez-Chico JL, Pérez de Isla L, Arístegui R, Masramon X, CORONARIA Study Group.
    J Int Med Res; 2008 Dec 10; 36(6):1399-417. PubMed ID: 19094452
    [Abstract] [Full Text] [Related]

  • 6. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ, Ceballos M, Grupo de tabajo sobre Calidad de la Hemodiálisis en Andalucía.
    Nefrologia; 2004 Dec 10; 24(2):149-57. PubMed ID: 15219090
    [Abstract] [Full Text] [Related]

  • 7. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 10; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of hypotension in hypertensive treated patients within the Primary Care setting. The PRESCAP 2010 study.
    Divisón-Garrote JA, Prieto-Díaz MÁ, Alonso-Moreno FJ, Velilla-Zancada SM, Escobar-Cervantes C, Llisterri-Caro JL, Cinza-Sanjurjo S, Rodríguez-Roca GC, Polo-García J, Pallarés-Carratalá V, members of the Working Group on Arterial Hypertension, Cardiovascular Disease of SEMERGEN, Members of the Working Group on Arterial Hypertension, Cardiovascular Disease of SEMERGEN.
    Semergen; 2020 Mar 10; 46(2):107-114. PubMed ID: 31395479
    [Abstract] [Full Text] [Related]

  • 9. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 10; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan.
    Liu J, Yasuno S, Oba K, Konda M, Ichihara C, Kitao H, Kuwabara Y, Ueshima K.
    J Hypertens; 2018 Sep 10; 36(9):1921-1928. PubMed ID: 29750680
    [Abstract] [Full Text] [Related]

  • 11. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT, Basile J, Wong ND, Whelton P, Dart RA, Thadani U, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Diabetes Care; 2008 Feb 10; 31(2):353-60. PubMed ID: 18000186
    [Abstract] [Full Text] [Related]

  • 12. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, Sweeney ME, Randall OS, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group.
    Diabetes Care; 2001 Apr 10; 24(4):654-8. PubMed ID: 11315826
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prevalence of chronic kidney disease in hypertensive aged women treated in primary care. MERICAP Study].
    Llisterri Caro JL, Barrios Alonso V, de la Sierra Iserte A, Escobar Cervantes C, González-Segura Alsina D.
    Med Clin (Barc); 2012 May 05; 138(12):512-8. PubMed ID: 21944650
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database.
    Holmqvist L, Boström KB, Kahan T, Schiöler L, Hasselström J, Hjerpe P, Wettermark B, Manhem K.
    J Am Soc Hypertens; 2016 Nov 05; 10(11):838-846. PubMed ID: 27707612
    [Abstract] [Full Text] [Related]

  • 17. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators.
    Lancet; 2016 Nov 05; 366(9489):895-906. PubMed ID: 16154016
    [Abstract] [Full Text] [Related]

  • 18. Are all the hypertensives made equal?
    Flaa A, Kjeldsen SE.
    Herz; 2006 Jun 05; 31(4):323-30. PubMed ID: 16810472
    [Abstract] [Full Text] [Related]

  • 19. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J, López-Gómez JM, Aljama P.
    Nefrologia; 2005 Jun 05; 25(3):297-306. PubMed ID: 16053011
    [Abstract] [Full Text] [Related]

  • 20. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NR, ASCOT Investigators.
    J Am Coll Cardiol; 2009 Sep 22; 54(13):1154-61. PubMed ID: 19761936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.